Cell immunity and recurrent miscarriage

Miscarriages: Causes, Symptoms and Prevention

Volumn , Issue , 2012, Pages 29-53

  Vaquero, Elena ^a,b,c   de Felice, Giovanna ^a   Valensise, Herbert ^a   Lazzarin, Natalia ^a,b,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Department of Anaesthesiology and Intensive Care   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894235097     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (80)

1. Stephenson M, Kutteh W. Evaluation and management of recurrent pregnancy loss. Clinical Obstet. Gynecol., 50: 132-145, 2007.
2. Rai R., Regan L. Recurrent miscarriage. Lancet
3. Edmonds DK, Lindsay KS, Miller JF et al. Early embryonic mortality in women. Fertil. Steril. 38:447-453, 1982.
4. Piccini MP, Romagnani S. Regulation of fetal allograft survival by hormone controlled TH1 and Th2 cytochines. Immunol. Rese 15:141-150, 1996.
5. Coulam CB Epidemiology of recurrent spontaneous abortion. Am. J. Reprod. Immunol. 26:23-27, 1991.
6. Stray-Pedersen B, Stray-Pedersen S (1984) Etiology factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol. 148:140-146, 1991.
7. Pandey MK, Rani R, Agraval S An update in recurrent spontaneous abortion. Arch. Gynecol. Obstet. 272:95-108, 2005.
8. Recurrent Miscarriage Immunotherapy Trialists Group (RMITG) World wide collaborative observation study and meta-analysis on allogenic leucocyte immunotherapy for recurrent spontaneous abortion. Am. J. Reprod. Immunol. 32:55-72, 1994.
9. Arch PC, Troutt AB, Clark DA Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion. Am. J. Reprod. Immunol. 37:262-266, 2007.
10. Clark A.D. Cell-Surface CD200 May Predict Efficacy of Paternal Mononuclear Leukocyte Immunotherapy in Treatment of Human Recurrent Pregnancy Loss. Am. J. Reprod. Immunol. 61: 75-84, 2009.
11. Calleja-Agius Jean, Brincat mark P. Recurrent miscarriages: What is the role of cytokines? Gynecological Endocrinologo, 24(12): 663-668, 2008.
12. Raghupathy Raj. Manipulation of cytokine production profiles as a therapeutic approach for immunological pregnancy loss. Indian J. of biochemistry and biophysics, 45: 225-236, 2008.
13. Chenyshov VP, Vodyanik MA, Pisareva S Lack of solubile TNF receptors in women with recurrent spontaneous abortion and possibility for its correction. Am. J. Reprod. Immunol. 54:284-291, 2005.
14. Yoon Kyong Choi1 Joanne Kwak-Kim1, Cytokine Gene Polymorphisms in Recurrent Spontaneous Abortions: A Comprehensive Review, American Journal of Reproductive Immunology 60: 91-110, 2008.
15. Clark DA, Ding JW, Yu G, Levy GA, Gorczynski R: (Fg. l2) prothrombinase expression in mouse throphoblast and decidua triggers abortion but may be countered by OX-2, Mol. Human Reprod. 7: 185-194, 2001.
16. Recurrent pregnancy loss: A disease of inflammation and coagulation. Joanne Kwak-Kim, Kwang Moon Yang, and Alice Gilman-Sachs, J. Obstet. Gynaecol. Res. 35, 4: 609-622, 2009.
17. Innate immunity, coagulation and placenta-related adverse pregnancy outcomes. Li M, Huang SJ. Thromb Res. 124(6):656-62, 2009.
18. Kotaro Kitaya. Accumulation of uterine CD16 (-) natural killer cells: friends, foes or Jekyll and Hyde relationship for the conceptus? Immunological investigation 17: 467-481, 2008.
19. Bulmer JN, Morrison L, Longfellow M et al Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum. Reprod. 6:791-798, 2004.
20. Ntrivalas EJ, Bowser CR, Kwak-Kim J et. al. Expression of killer Immunoglobulin-like receptors on peripheral blood NK cells subset of women with recurrent spontaneous abortion or implantation failure. Am. J. Reprod. Immunol. 53:215-221, 2005.
21. Coulam CB, Goodman C, Roussev RG et al Systemic CD56+ cells can predict pregnancy outcome. Am. J. Reprod. Immunol. 33:40-46, 1995.
22. Mayer K, Meyer S, Reinholz-Muhly M. et al. Short-time infusion of fish-oil based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J. Immunol., 171:4837-4843, 2003.
23. Rai R, Sacks G, Trew G New debate: natural killer cells and reproductive failure-theory, practice and prejudice. Human Reprod. 10:1-4, 2005.
24. Immunophenotype of Peripheral T Lymphocytes, NK Cells and expression of CD69 Activation Marker in Patients with Recurrent Spontaneous Abortions, During the Mid-Luteal Phase. Aramilena Prado-Drayer1, JoséTeppa2, Pedro Sánchez1, María Isabel Camejo, American Journal of Reproductive Immunology 60 (2008) 66-74, 2008.
25. Szekeres Bartho Julia, Balash Juan. Progestagen therapy for recurrent miscarriage. Human Reprod. Update, 14 (1).27-35, 2008.
26. R. Raghupathy, E. Al-Mutawa a, M. Al-Azemi b, M. Makhseedb, F. Azizieh a, J. Szekeres-Bartho: " Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery". Journal of Reproductive Immunology 80: 91-9, 2009.
27. Progesterone-mediated immunomodulation Szekeres-Bartho J. Immunotherapy. (5):873-82, 2009.
28. HLA-G and pregnancy adverse outcomes. Cecati M, Giannubilo SR, Emanuelli M, Tranquilli AL, Saccucci F. Med. Hypotheses. 76(6):782-4, 2011.
29. Moffet A, Loke YW. The immunological paradox of pregnancy: a reappraisal. Placenta 25:1-8, 2004.
30. Repertoire and Clonality of T-Cell Receptor Beta Variable Genes Expressed in Endometrium and Blood T Cells of Patients with Recurrent Spontaneous Abortion, Pouneh Dokouhaki1, 2, Rosa Moghaddam3, MohammadReza Rezvany4, Jamileh Ghassemi5, Marefat Ghaffari Novin6, Amirhassan Zarnani5,7, Mohammah-Mehdi Akhondi8, Mahyar Ostadkarampour9,10, Håkan Mellstedt11, Alireza Razavi1, Mahmood Jeddi-Tehrani. American Journal of Reproductive Immunology 60:160-171, 2008.
31. Wang X, Ma Z, Hong Y et al. The skewed TCR-BV repertoire displayed at the maternal-fetal interface of women with unexplained pregnancy loss. Am. J. Reprod. Immunol. 54:84-95, 2005.
32. Pouneh Dokouhaki, Rosa Moghaddam, Mohammad Reza Rezvany, et al. Repertoire and Clonality of T-Cell Receptor Beta Variable Genes expressed in Endometrium and Blood T Cells of Patients with recurrent Spontaneous Abortion. Am. J. Reprod. Immunol, 60: 160-171, 2008.
33. Joining the Immunological Dots in Recurrent Miscarriage. Amolak Singh Bansal Am. J. Reprod. Immunol. 64: 307-315, 2010.
34. CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction, J. Immunol. 178 2572-2578, 2007.
35. G.A. Prieto, Y. Rosenstein, Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation, Immunology 118:58-65, 2006.
36. A physiological role for inducible FOXP3+ TREG cellsB. Lessons from women with reproductive failure Lourdes Arruvito, Ana I. Sotelo, Ariel Billordo, Leonardo Fainboim, Clinical Immunology 136, 432-441, 2010.
37. Clark AJRI 59: 277/300 (2008).
38. Matsubayashi H, Shida M, Kondo A et al. Preconceptional peripheral natural killer cell activity as a predictor of pregnancy outcome in patients with unexplained infertility. Am. J. Reprod. Immunol. 53:126-131, 2005.
39. Vaquero E, Lazzarin N, Caserta D et al Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. European J. Obstet. Gynaecol. Reprod. Biol., 125:79-84, 2006.
40. Kwat-Kim JY, Beaman KD, Gilman Sachs A et al. Up regulated expression of CD56+,CD56+/CD16+ and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 35:376-382, 1996.
41. Emmer PM, Nelen WL, Steegers EA et al. Peripheral natural killer cytotoxicity and CD56+CD16+ cells increased during early pregnancy in women with a history of recurrent spontaneous abortion. Human Reprod., 35:1163-1169, 2000.
42. Yamada H, Kato EH, Kobayashi G et al. High NK cells activity in early pregnancy correlates with subsequent labor.
43. Ruiz JE, Kwak-Kim JY, Baum L et al. Intravenous immunoglobulin inhibits natural killer cells activity in vivo in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 35:370-375, 1996.
44. Morikawa M, Yamada H, Kato EH et al. Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained ethiology: down regulation of NK cell activity and subset. Am. J. Reprod. Immunol. 46:399-404, 2001.
45. Rai R., Sacks G, Trew G. NK cells and reproductive failure-theory practice and prejudice: Human reprod. 20: 1123-1126, 2005.
46. Detailed analysis of natural killer (NK) cells in women with recurrent miscarriage. K. King, S. Smith, M. Chapman, and G. Sacks, Human Reproduction, Vol.25, No.1 pp. 52-58, 2010.
47. Reznikoff-Etievant MF, Cayol V, Zou GM, Abuaf N, Robert A, Johanet C, Milliez J: Habitual abortions in 678 healthy patients: investigation and prevention. Human Reprod. 1999; 14:2106-2109.
48. Hasegawa I, Yamamoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, Tanaka K: Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil. Steril. 70:1044-1048,1998.
49. Many A, Pauzner R, Carp H, Langevitz P, Martinowitz U: Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol 1992; 28:216.
50. Passaleva A, Massai G, D'Elios MM, Livi C, Abbate R: (1992) Prevention of miscarriage in antiphospholipid syndrome. Autoimmunity; 14:121-125, 1992.
51. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, Farine D, Spitzer K, Fielding L, Solonika CA et al.: Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N. Engl. J. Med. 337:148-153, 1997.
52. Passaleva A, Massai G, D'Elios MM, Livi C, Abbate R: (1992) Prevention of miscarriage in antiphospholipid syndrome. Autoimmunity 14:121-125, 1992.
53. Quenby S, Kalumbi C, Bates M et al. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil. Steril. 84:980-984, 2004.
54. Koopman LA, Kopcow HD, Rybalow B et al Human maternal natural killer cells are a unique NK cells subset with immunomodulatory potential. J. Exp. Med. 198:1201-1212, 2003.
55. Hasegawa I, Yamamoto Y, Suzuki M et al. Prednisolone plus low dose aspirin improves implantation rate in woman with autoimmune conditions who are undergoing in vitro fertilization. Fertil. Steril. 70:1044-1048, 1998.
56. Ogasara M, Aoki K. Successful uterine steroid therapy in a case with a history of ten miscarriages. Am. J. Reprod. Immunol. 44:253-255, 2000.
57. Ubaldi F, Rienzi L, Ferrero S et al. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Human Reprod. 17:1544-1547, 2002.
58. Moffit D, Queenan JT, Veeck LL et al. Low dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. Fertil. Steril. 63:571-577, 1995.
59. Julia Szekeres Bartho, Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage. Immunotherapy 1(5), 873-882, 2009.
60. Goldstein P, Berrier J., Rosen S., Sack S., et al. A meta-analysis of randomized-controlled trials of progestational agents in pregnancy. Br. J. Obstet. Gynecol.; 96:265-274, 2006.
61. Daya S. Efficacy of progesterone support for pregnancy in women with RM. A meta-analysis of controlled trials. Br. J. Obstet. Gynecol.; 96: 275-280, 1989.
62. Coulam CB, Krysa L, Stern J, Bustillo M Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am. J. Reprod. Immunol. 34:333-337, 1995.
63. Stephenson M, Dreher K, Houlihan E, Wu V Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blind, placebo controlled trial. Am. J. Reprod. Immunol. 39:82-88, 1998.
64. Christiansen OB. Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: The European Experience. Am. J. Reprod. Immunol. 39:77-81, 1998.
65. The German RSA/IVIG group Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br. J. Obstet. Gynaecol. 101:1072-1077, 1994.
66. Daya S, Gunby J, Clark D Intravenous immunoglobulin therapy for recurrent spontaneous abortion: A meta-analysis. Am. J. Reprod. Immunol. 39:69-76, 1998.
67. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M: Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. Br. J. Obstet. Gynaecol. 114:134-142, 2007.
68. Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarranto A, Licata G: Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with anti-phospholipid antibodies. Arth. Rheum. 48:728-731, 2003.
69. Perricone R, Di Muzio G, Perricone C et al. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high dose intravenous immunoglobulin. Am. J. Reprod. Immunol. 55:232-239, 2006.
70. Clark D, Daya S Editorial. Is there a hope for IVIG? Am. J. Reprod. Immunol. 39:65-68, 1998.
71. Clark DA, Chaouat G: Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am. J. Reprod. Immunol. 53:13-20, 2005.
72. Winger EE, Reed JL, Stricker RB: Treatment with tumor necrosis factor (TNF) inhibitors and intravenous immunoglobulin (IVIG) improves live birth rates in women with recurrent spontaneous abortion (RSA). Am. J. Reprod. Immunol. 58:225, 2007.
73. Tezuka H, Sawada H, Sakoda H, et al. Suppression of genetic resistance to bone marrow grafts and natural killer activity by administration of fat emulsion. Exp. Hematol. 12:609-612, 1988.
74. Granato D, Blum S, Rossle C, Le Boucher J, Malnos A, Dutot G: Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J. Parenter. Enterak. Nutr.; 24:113-118, 2000.
75. Roumen G. Roussev, Brian Acacio, Siu C. Ng, Carolyn B. Coulam. Duration of Intralipid's Suppressive Effect on NK Cell's Functional Activity. Am. J. Reprod. Immunol. 60: 258-263, 2008.
76. Chaouat G, Clark DA, Wegmann TG: Genetic aspects of the CBAxDBA/2 and B10xB10.A models of murine pregnancy failure and its prevention by lymphocyte immunization. In Early Pregnancy Loss: Mechanisms and Treatment, RW Beard, F Sharp(eds). Ashton-under-Lyne, Royal College of Obstetricians and Gynaecologists, Peacock Press, 89-102, 1988.
77. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood J, Beard RW: Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet 1:941-943, 1985.
78. Recurrent Miscarriage Immunotherapy Trialists Group (RMITG): Worldwide prospective observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am. J. Reprod. Immunol. 32:55-72, 1994.
79. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunization in prevention of recurrent miscarriages: a randomized trial. Lancet 354:365-369, 1999.
80. Pandey MK, Agrawal S: Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization from women with recurrent spontaneous abortion. International Immunopharmacol. 4:289-298, 2004.